moderate - Post-acute care demand is relatively recession-resistant as critical illness volumes are non-discretionary, but outpatient rehabilitation and Concentra's occupational health services show cyclical sensitivity. During economic downturns, elective procedures decline reducing LTACH referrals, while workers' compensation volumes correlate with employment levels and workplace activity. Consumer spending impacts patient ability to meet co-pays and deductibles for outpatient services. However, aging demographics (65+ population growth) provide structural tailwind offsetting cyclical pressures.

Rising interest rates increase borrowing costs on Select Medical's $1.2B debt (mix of term loans and revolving credit), directly impacting interest expense and free cash flow available for growth investments. Higher rates also compress valuation multiples for healthcare services stocks as investors rotate to fixed income. However, the company's moderate leverage (0.61x D/E) and positive free cash flow generation ($500M TTM) limit refinancing risk. Rate increases have minimal direct impact on operating performance as reimbursement rates are government-determined rather than market-driven.

value - The stock trades at 0.5x P/S and 1.2x P/B with 26.7% FCF yield, attracting deep value investors focused on cash generation and potential multiple re-rating. Recent 27% three-month rally suggests momentum investors entering after operational stabilization. The combination of government reimbursement exposure, labor cost pressures, and modest growth profile limits appeal to growth investors. Lack of dividend (implied by focus on debt paydown) reduces income investor interest. Hedge funds and distressed-oriented investors monitor given healthcare services sector volatility.